LV Biotech is a technology-oriented enterprise specializing in primary cells separation, frozen storage and regeneration in China. It has obtained the national high-tech enterprise, Biosafety Second-level laboratory, ISO9001 quality management system, GB/T29490-2013 intellectual property standards and other qualifications.

After years of dedicated research and development, the company has successfully conquered primary hepatocyte isolation, cryopreservation and recovery technology.

The company is transforming previous research results, aiming at advanced liver failure diseases, focusing on new precision medicine technologies in the future, and developing new products and technologies such as allogeneic liver cell transplantation, regenerative liver cell transplantation, artificial liver, etc., to meet the major clinical needs of Shenzhen and even the whole world. It will also explore a broader space for the stable source of samples from the primary hepatocyte bank, the sharing of human heritage resources and the value of samples for scientific research.